Results Snapshot
Figures in Cr
Standalone Annual Results
Mar'26
Mar'25
Mar'24
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 23.97% vs 28.42% in Mar 2025
Standalone Net Profit
YoY Growth in year ended Mar 2026 is -38.75% vs 160.87% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 114.77% vs 141.82% in Mar 2025
Interest
No Interest in the last few periods
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2026 has improved from Mar 2025
Compare Annual Results Of Niva Bupa Health With
Figures in Cr
Standalone Annual Results
Change(INR)
Change(%)
Net Sales
6,067.57
35,367.84
-29,300.27
-82.84%
Other Operating Income
627.12
8,023.50
-7,396.38
-92.18%
Total Operating income
6,694.69
43,391.34
-36,696.65
-84.57%
Raw Material Cost
0.00
0.00
0.00
Purchase of Finished goods
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
Employee Cost
675.24
2,612.50
-1,937.26
-74.15%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
5,359.34
37,782.80
-32,423.46
-85.82%
Selling and Distribution Expenses
124.40
0.00
124.40
Other Expenses
410.93
2,053.99
-1,643.06
-79.99%
Total Expenditure (Excl Depreciation)
6,569.91
42,449.29
-35,879.38
-84.52%
Operating Profit (PBDIT) excl Other Income
124.78
942.05
-817.27
-86.75%
Other Income
2.03
92.43
-90.40
-97.80%
Operating Profit (PBDIT)
126.81
1,034.48
-907.67
-87.74%
Interest
0.00
0.00
0.00
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
126.81
1,034.48
-907.67
-87.74%
Depreciation
0.00
0.00
0.00
Profit Before Tax
126.81
1,034.48
-907.67
-87.74%
Tax
-3.97
46.41
-50.38
-108.55%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
130.78
988.07
-857.29
-86.76%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
130.78
988.07
-857.29
-86.76%
Equity Capital
1,847.46
824.00
1,023.46
124.21%
Face Value
10.00
5.00
0.00
Reserves
1,371.51
21,060.22
-19,688.71
-93.49%
Earnings per share (EPS)
0.71
6.00
-5.29
-88.17%
Diluted Earnings per share
0.71
6.00
-5.29
-88.17%
Operating Profit Margin (Excl OI)
2.06%
2.66%
0.00
-0.60%
Gross Profit Margin
2.09%
2.92%
0.00
-0.83%
PAT Margin
2.16%
2.79%
0.00
-0.63%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 6,067.57 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 23.97% vs 28.42% in Mar 2025
Annual - Standalone Net Profit
Standalone Net Profit 130.78 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -38.75% vs 160.87% in Mar 2025
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 124.78 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 114.77% vs 141.82% in Mar 2025
Annual - Interest
No Interest in the last few periods
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 2.06%
in Mar 2026Figures in %
YoY Growth in year ended Mar 2026 has improved from Mar 2025






